GAMMAGARD LIQUID is a ready-to-use liquid medicine that is given in a vein (intravenously) or under the skin (subcutaneously) to treat primary immunodeficiency (PI) in people 2 years and older.
What to know about GAMMAGARD LIQUID
In the clinical study to look at the safety and effectiveness of GAMMAGARD LIQUID subQ, 47 patients with primary immunodeficiency (PI) were treated for about 1 year (54 weeks on average, with a range of 8 to 68 weeks overall). Patients receiving GAMMAGARD LIQUID showed protection against infection.
*A patient-year is a patient experience in a clinical trial over the course of 1 year.
†Validated acute serious bacterial infection (ASBI).
‡3 patients had pneumonia, which didn’t need hospitalization.
Of the 348 non-serious side effects reported in patients treated with subQ GAMMAGARD LIQUID, 228 were considered mild and 112 moderate. The remaining 8 were severe.
In 55 out of 2,294 infusions, side effects at the injection site were reported, including mild or moderate pain, swelling, itching, redness, bruising, and/or warmth.
When giving yourself infusions at home, you should have another responsible person present to help treat side effects or get help if a serious adverse reaction should occur. Ask your doctor whether you should have rescue medications on hand, like antihistamines or epinephrine, and what to expect with subQ infusions.
*After a few training sessions with a nurse.
IMPORTANT SAFETY INFORMATION and serious warnings regarding blood clots, decreased kidney function or kidney failure
What is the most important information that I should know about GAMMAGARD LIQUID?
GAMMAGARD LIQUID can cause the following serious reactions: severe allergic reactions causing difficulty in breathing or skin rashes; decreased kidney function or kidney failure; blood clots in the heart, brain, lungs or elsewhere in the body; severe headache, drowsiness, fever, painful eye movements, or nausea and vomiting; dark colored urine, swelling, fatigue, or difficulty breathing.
INDICATION
What is GAMMAGARD LIQUID?
GAMMAGARD LIQUID is a ready-to-use liquid medicine that is given in a vein (intravenously) or under the skin (subcutaneously) to treat primary immunodeficiency (PI) in people 2 years and older.
Important Safety Information
What is the most important information that I should know about GAMMAGARD LIQUID?
GAMMAGARD LIQUID can cause the following serious reactions:
Who should not use GAMMAGARD LIQUID?
Do not use GAMMAGARD LIQUID if you:
What should I avoid while taking GAMMAGARD LIQUID?
What are the possible or reasonably likely side effects of GAMMAGARD LIQUID?
GAMMAGARD LIQUID can cause serious side effects. If any of the following problems occur after starting GAMMAGARD LIQUID, stop the infusion immediately and contact your HCP or call emergency services:
The following one or more possible reactions may occur at the site of infusion of GAMMAGARD LIQUID for PI, generally go away within a few hours, and are less likely after the first few infusions:
During the infusion of GAMMAGARD LIQUID for PI, look out for the first signs of the following common side effects:
These are not all the possible side effects. Talk to your HCP about any side effect that bothers you or that does not go away.
For additional safety information including Warning about Blood Clots, Decreased Kidney Function, and Kidney Failure, click for Information for Patientsopens in a new tab and discuss with your HCP.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatchopens in a new tab, or call 1-800-FDA-1088.